Xeris Pharmaceuticals | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Adcock Ingram Holdings ZAR 14.68M 427K 2024-06
Celltrion KRW 220.45B 27.97M 2024-09
Cspc Pharmaceutical CNY 11.03B 26.91M 2024-12
Dianthus Therapeutics USD 31K 2K 2024-12
Ecofibre AUD 120.81M 134K 2024-06
Eli Lilly USD 592.4M 1.5M 2024-12
Kangmei Pharma CNY 13.86B 0 2024-09
Knight Therapeutics CAD 539.32M 1.63M 2024-09
Laboratorios Farma EUR 3.24M 0 2023-06
Malin Corporation EUR 200K 0 2024-06
Medical Developments International AUD 105.73M 0 2024-06
Neuren Pharmaceuticals AUD 165.27M 10.43M 2024-12
Organigram Holdings CAD 892.59M 39.7M 2024-12
Pacira USD 47K 0 2024-12
Perrigo USD 6.73B 30M 2024-12
Pharma Mar EUR 10.93M 80K 2024-12
Qiagen NV USD 2.6M 0 2024-09
Sartorius EUR 69M 600K 2024-09
Sino Biopharmaceutical CNY 414.38M 0 2024-12
Supernus Pharmaceuticals USD 56K 1000 2024-12
Tilray USD 93K 5K 2024-11
Zz Pientze Pharmaceu 603.32M 0 2024-09



Xeris Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.